Tenoxicam

Chemical formula: C₁₃H₁₁N₃O₄S₂  Molecular mass: 337.37 g/mol  PubChem compound: 54677971

Active ingredient description

Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) which has anti-inflammatory, analgesic, antipyretic properties and it also inhibits platelet aggregation.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
M01AC02 Tenoxicam M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams
Discover more medicines within M01AC02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
MOBIFLEX Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 59804-37-4
DrugBank Drug: DB00469
KEGG Drug: D01767
PubChem Compound: 54677971
RxNorm Ingredient: 37790
SNOMED-CT Concept: 395898001
Tenoxicam (substance)
UNII Identifier: Z1R9N0A399
TENOXICAM

Medicines

Tenoxicam is an active ingredient of these brands:

Cyprus (CY)

France (FR)

Hong Kong (HK)

New Zealand (NZ)

Nigeria (NG)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.